In 2021, Alabama took a significant step by approving a medical marijuana program, promising relief for patients with qualifying conditions. However, three years later, patients are still waiting for access to cannabis products. The delays have been attributed to bureaucratic hurdles and regulatory challenges that have slowed the program’s implementation.

Despite the initial optimism, the state has struggled to establish a functional system for the cultivation, distribution, and sale of medical marijuana. Patients, many of whom suffer from chronic pain and other debilitating conditions, continue to express frustration over the prolonged wait.

For more details on the ongoing delays and the impact on patients, read the full article on Michigan’s Thumb here.